O’Ryan.Health, a leader in at-home pediatric healthcare innovation, today announced it has become the first US company to launch two, parent-led observational studies “The Healthy Kids Study” and “The JDM Study,” involving the in-home collection of pediatric blood from children. Juvenile Dermatomyositis (JDM) is an ultra-rare pediatric autoimmune disorder. These studies, made possible through a partnership with YourBio Health, a pioneer in capillary blood sampling, allow parents to safely and efficiently sample their children’s blood without having to travel to a medical facility.
Voice AI company SuperDial helps billing and provider organizations reclaim time and revenue by replacing hours of insurer calls with end-to-end AI agents.
The debt and equity series A round was led by SignalFire, with participation from Slow Ventures, Box…
According to recent survey data pending review and publication (Rousmaniere et al. 2025) yet widely circulated, 48.7 percent of 499 U.S. respondents reported using LLMs (large language models) for psychological support in the preceding year. The majority did this for anxiety,…